Good morning :)
Place Order
Add to Watchlist

Dhanvantri Jeevan Rekha Ltd

ZDHJERK

Dhanvantri Jeevan Rekha Ltd

ZDHJERK
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹9 cr, stock is ranked 4,504
High RiskStock is 4.67x as volatile as Nifty
22.204.96% (+1.05)
22.204.96% (+1.05)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹9 cr, stock is ranked 4,504
High RiskStock is 4.67x as volatile as Nifty

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹9 cr, stock is ranked 4,504
High RiskStock is 4.67x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
15.160.96—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.496.670.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dhanvantri Jeevan Rekha is engaged in the business of health and medical services. The Company provides diagnostic and hospital services in the field of urology, cardiology, neurology, internal medicine and radiology.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 4.12%, vs industry avg of 10.02%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.05% to 0.03%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 30.26%, vs industry avg of 42.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue9.5711.5413.9616.9618.379.9616.9817.9220.7522.05
Raw Materialssubtract0.000.001.562.263.350.000.000.000.0020.74
Power & Fuel Costsubtract0.340.490.540.520.560.460.590.630.66
Employee Costsubtract2.032.162.753.733.582.363.223.784.26
Selling & Administrative Expensessubtract0.384.586.688.359.444.786.777.068.40
Operating & Other expensessubtract5.062.810.440.750.612.934.705.646.31
Depreciation/Amortizationsubtract0.270.371.101.131.101.041.020.960.870.71
Interest & Other Itemssubtract0.080.180.220.110.040.020.020.010.010.01
Taxes & Other Itemssubtract0.460.42-0.050.07-0.05-0.210.190.070.09-0.01
EPS2.231.261.710.10-0.62-3.371.12-0.550.361.43
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Dhanvantri Jeevan Rekha Ltd60.660.96—
Max Healthcare Institute Ltd106.2313.360.13%
Apollo Hospitals Enterprise Ltd116.1914.260.22%
Fortis Healthcare Ltd84.745.930.15%

Price Comparison

Compare ZDHJERK with any stock or ETF
Compare ZDHJERK with any stock or ETF
ZDHJERK
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding19.65%0.00%0.00%0.00%80.35%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ZDHJERK has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 15, 2011

Final
Final | Div/Share: ₹0.40

Dividend/Share

₹0.40

Ex DateEx Date

Sep 15, 2011

News & Opinions
Earnings
Dhanvantri Jeevan Rekha reports standalone net profit of Rs 0.17 crore in the September 2024 quarter

Net profit of Dhanvantri Jeevan Rekha reported to Rs 0.17 crore in the quarter ended September 2024 as against net loss of Rs 0.15 crore during the previous quarter ended September 2023. Sales rose 10.61% to Rs 5.42 crore in the quarter ended September 2024 as against Rs 4.90 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.424.90 11 OPM %4.430.61 - PBDT0.330.10 230 PBT0.17-0.15 LP NP0.17-0.15 LP Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Dhanvantri Jeevan Rekha schedules board meeting

Dhanvantri Jeevan Rekha will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Dhanvantri Jeevan Rekha to conduct board meeting

Dhanvantri Jeevan Rekha will hold a meeting of the Board of Directors of the Company on 31 October 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Dhanvantri Jeevan Rekha to hold AGM

Dhanvantri Jeevan Rekha announced that the 31th Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Dhanvantri Jeevan Rekha to conduct board meeting

Dhanvantri Jeevan Rekha will hold a meeting of the Board of Directors of the Company on 26 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Dhanvantri Jeevan Rekha standalone net profit rises 220.00% in the June 2024 quarter

4 months agoBusiness Standard
Earnings
Dhanvantri Jeevan Rekha standalone net profit rises 220.00% in the June 2024 quarter

Net profit of Dhanvantri Jeevan Rekha rose 220.00% to Rs 0.16 crore in the quarter ended June 2024 as against Rs 0.05 crore during the previous quarter ended June 2023. Sales rose 14.46% to Rs 5.70 crore in the quarter ended June 2024 as against Rs 4.98 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales5.704.98 14 OPM %4.394.62 - PBDT0.330.29 14 PBT0.160.05 220 NP0.160.05 220 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Dhanvantri Jeevan Rekha to table results

Dhanvantri Jeevan Rekha will hold a meeting of the Board of Directors of the Company on 31 July 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live